Loading...
Powered By
18 items
2025-06-29
Maruo Calcium Co., Ltd. announced that they will report Q1, 2026 results on Aug 07, 2025
2025-05-30
Maruo Calcium Co., Ltd. expected to report Q1 2026 results on August 8, 2025. This event was calculated by S&P Global (Created on May 30, 2025).
2025-05-23
Maruo Calcium Co., Ltd. expected to report Q4 2025 results on May 29, 2025. This event was calculated by S&P Global (Created on May 23, 2025).
2025-05-14
From May 13, 2025 to May 14, 2025, the company has repurchased 80,100 shares, representing 3.69% for ¥107.33 million. With this, the company has completed the repurchase of 80,100 shares, representing 3.69% for ¥107.33 million under the buyback announced on May 13, 2025.
2025-05-14
The company closed its plan on May 14, 2025.
2025-05-14
Maruo Calcium Co., Ltd. (TSE:4102) announces a share repurchase program. Under the program, the company will repurchase up to 100,000 shares, representing 4.61% of its issued share capital (excluding treasury stock), for a total purchase price of ¥134 million. The shares will be repurchased at a price of ¥1,340 per share. The purpose of the program is to improve capital efficiency and implement a flexible capital policy that responds to changes in the business environment. The program will expire on May 14, 2025. As of March 31, 2025, the company had 2,169,334 issued shares (excluding treasury stock) and 185,866 treasury shares.
2025-05-14
The Board of Directors of Maruo Calcium Co., Ltd. has authorized a buyback plan on May 13, 2025.
2025-05-12
Maruo Calcium Co., Ltd., Annual General Meeting, Jun 26, 2025.
2025-03-02
Maruo Calcium Co., Ltd. announced that they will report fiscal year 2025 results on May 12, 2025
2025-02-07
Maruo Calcium Co., Ltd. expected to report Fiscal Year 2025 results on May 9, 2025. This event was calculated by S&P Global (Created on February 7, 2025).
2024-12-13
Maruo Calcium Co., Ltd. announced that they will report Q3, 2025 results on Feb 07, 2025
2024-11-13
From November 12, 2024 to November 13, 2024, the company has repurchased 60,000 shares, representing 2.71% for ¥79.5 million. With this, the company has completed the repurchase of 60,000 shares, representing 2.71% for ¥79.5 million under the buyback announced on November 12, 2024.
2024-11-13
The company closed its plan on November 13, 2024.
2024-11-12
Maruo Calcium Co., Ltd. (TSE:4102) announces a share repurchase program. Under the program, the company will repurchase up to 80,000 shares, representing 3.59% of its issued share capital (excluding treasury stock), for a total purchase price of ¥106 million. The shares will be repurchased at a price of ¥1,325 per share. The purpose of the program is to improve capital efficiency and carry out flexible capital policies in response to changes in the business environment. As of September 30, 2024, the company had 2,229,334 issued shares (excluding treasury stock) and 125,866 treasury shares.
2024-11-12
The Board of Directors of Maruo Calcium Co., Ltd. has authorized a buyback plan on November 12, 2024.
2024-11-12
Maruo Calcium Co., Ltd., ¥ 30.0, Cash Dividend, Mar-28-2025
2024-11-11
Maruo Calcium Co., Ltd. expected to report Q3 2025 results on February 7, 2025. This event was calculated by S&P Global (Created on November 11, 2024).
2024-08-29
Maruo Calcium Co., Ltd. announced that they will report Q2, 2025 results on Nov 11, 2024
2025Q2 | 2025Q1 | 2024Q4 | 2024Q3 | 2024Q2 | 2024Q1 | 2023Q4 | 2023Q3 | |
|---|---|---|---|---|---|---|---|---|
Total Revenues | 12,559 | 12,843 | 13,009 | 13,078 | 13,086 | 12,889 | 12,819 | 12,719 |
Pretax Income Excl.Unusual Items | 78 | 196 | 239 | 255 | 358 | 358 | 340 | 278 |
Total Assets | 17,325 | 16,869 | 17,417 | 18,529 | 18,989 | 17,010 | 17,024 | 16,711 |
Total Liabilities | 7,197 | 6,662 | 7,405 | 8,415 | 8,946 | 7,024 | 7,078 | 6,988 |
Cash & Cash Equivalents | 2,794 | 2,389 | 2,516 | 4,812 | 4,791 | 3,145 | 2,977 | 3,097 |
Total Common Equity | 9,730 | 9,800 | 9,643 | 9,724 | 9,663 | 9,614 | 9,540 | 9,319 |
Book Value Per Share (BVPS) | 4,569.61 | 4,517.52 | 4,445.14 | 4,361.84 | 4,366.6 | 4,344.46 | 4,310.99 | 4,121.15 |
Net Change in Cash | -786 | 1,370 | -566 | -1,051 | ||||
Capital Expenditure | -863 | -592 | -301 | -621 |
On August 07, 2025, Maruo Calcium shared its financial results for the second quarter of 2025, having revenues of 2.99B yen and net income of 0 yen, reflecting a 8.7% decline in revenue, along with a sharp drop of approximately 99.4% in EPS compared with the same quarter last year.
In addition, the EBITDA margin droped sharply from 5% in the corresponding quarter last year to 3.1%. A decrease in operating profitability may indicate a difficulty in sales or an increase in operating expenses, potentially harming the stock's future performance. and it trades at 33.5x times current year's earnings, which is higher than the sector average (P/E 13.4x).